Imago Pharmaceuticals, Inc.
Records under this name other than patents Imago Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Imago Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,884,828 | Substituted cinnolines as inhibitors of LRRK2 kinase activity Lapsed on the fee record Ended Feb 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 6, 2026 | From the USPTO record |
| US 8,450,363 | Inhibitors of Jun N-Terminal Kinase Lapsed on the fee record Ended May 28, 2025 · High confidence | Lapsed on the fee record | Ended May 28, 2025 | High confidence |
| US 10,766,954 | Therapeutic antibodies for treatment of neurodegeneration Lapsed on the fee record Ended Sep 8, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2024 | From the USPTO record |
| US 9,073,891 | Inhibitors of Jun N-Terminal Kinase Lapsed on the fee record Ended Jul 7, 2023 · High confidence | Lapsed on the fee record | Ended Jul 7, 2023 | High confidence |
| US 9,796,706 | Inhibitors of Jun N-terminal kinase Lapsed on the fee record Ended Oct 24, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 24, 2021 | From the USPTO record |
| US 9,493,485 | Spirocyclic Dihydro-Thiazine and Dihydro-Oxazine Bace Inhibitors, and Compositions and Uses Thereof Lapsed on the fee record Ended Nov 15, 2020 · High confidence | Lapsed on the fee record | Ended Nov 15, 2020 | High confidence |
| US 7,790,365 | Assays for Modulators of Parkin Activity Using S5A as a Parkin Substrate Lapsed on the fee record Ended Sep 7, 2018 · High confidence | Lapsed on the fee record | Ended Sep 7, 2018 | High confidence |